352 related articles for article (PubMed ID: 18242018)
1. Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
Khalil IA; Kogure K; Futaki S; Harashima H
Int J Pharm; 2008 Apr; 354(1-2):39-48. PubMed ID: 18242018
[TBL] [Abstract][Full Text] [Related]
2. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
3. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
Fujiwara T; Akita H; Harashima H
Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
[TBL] [Abstract][Full Text] [Related]
4. Non-viral gene delivery using nanoparticles.
Ditto AJ; Shah PN; Yun YH
Expert Opin Drug Deliv; 2009 Nov; 6(11):1149-60. PubMed ID: 19780712
[TBL] [Abstract][Full Text] [Related]
5. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
Khalil IA; Kogure K; Futaki S; Harashima H
J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716
[TBL] [Abstract][Full Text] [Related]
6. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
7. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.
Khalil IA; Kogure K; Akita H; Harashima H
Pharmacol Rev; 2006 Mar; 58(1):32-45. PubMed ID: 16507881
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging.
Kogure K; Akita H; Harashima H
J Control Release; 2007 Oct; 122(3):246-51. PubMed ID: 17651856
[TBL] [Abstract][Full Text] [Related]
9. Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound.
Negishi Y; Omata D; Iijima H; Takabayashi Y; Suzuki K; Endo Y; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
Mol Pharm; 2010 Feb; 7(1):217-26. PubMed ID: 20020739
[TBL] [Abstract][Full Text] [Related]
10. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
11. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems.
Hama S; Akita H; Ito R; Mizuguchi H; Hayakawa T; Harashima H
Mol Ther; 2006 Apr; 13(4):786-94. PubMed ID: 16364692
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
13. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.
Cryan SA; Devocelle M; Moran PJ; Hickey AJ; Kelly JG
Mol Pharm; 2006; 3(2):104-12. PubMed ID: 16579639
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery for lung cancer using nonviral gene vectors.
Wang JT; Peng DY; Chen M; Ye JS
Pharmazie; 2007 Oct; 62(10):723-6. PubMed ID: 18236772
[TBL] [Abstract][Full Text] [Related]
15. Lipidic vector systems for gene transfer.
Lee RJ; Huang L
Crit Rev Ther Drug Carrier Syst; 1997; 14(2):173-206. PubMed ID: 9107521
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.
Khalil IA; Futaki S; Niwa M; Baba Y; Kaji N; Kamiya H; Harashima H
Gene Ther; 2004 Apr; 11(7):636-44. PubMed ID: 14973542
[TBL] [Abstract][Full Text] [Related]
17. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
Torchilin VP
Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
[TBL] [Abstract][Full Text] [Related]
18. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology.
Suzuki R; Takizawa T; Negishi Y; Utoguchi N; Maruyama K
Int J Pharm; 2008 Apr; 354(1-2):49-55. PubMed ID: 18082343
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons.
Bergen JM; Pun SH
J Gene Med; 2008 Feb; 10(2):187-97. PubMed ID: 18064730
[TBL] [Abstract][Full Text] [Related]
20. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
